Accenture (ACN) is attractive at current prices due to a significant pullback, offering a 5%+ dividend yield, historical double-digit dividend growth, and potential for multiple expansion.
Source Post
4 Stocks Set To Double (With The Math to Prove it!) 🚀
The creator discusses the importance of long-term price targets based on earnings growth rather than short-term sentiment-driven valuation multiples. They aim to project 2030 price targets for four stocks, with the goal of identifying those with the potential to double by that year. The first stock analyzed is Microsoft (MSFT), noting its recent price decline despite earnings growth, leading to historically low valuation multiples.
Linked Mentions
Tickers discussed in this post
UnitedHealth Group is expected to see a strong earnings recovery, with a projected 21% EPS CAGR through 2030, suggesting significant upside potential.
Meta is trading at historically low valuation multiples and has strong projected EPS growth through 2030, creating potential for significant long-term returns.
Microsoft (MSFT) is discussed as the first stock for a 2030 price target calculation, noting its recent price drop and historically low PE multiple.